Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer.
Görkem EskiizmirGizem Çalıbaşı KoçalTuğba UysalHülya EllidokuzYasemin BaşpınarPublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2021)
This is the first clinical study in which the diagnostic, predictive and prognostic roles of hypoxia-related biomolecules were examined in laryngeal neoplasms. Hypoxia-inducible factor-2 is a prognostic factor in larynx cancer irrespective of treatment modality.